-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS ANNOUNCES ORPHAN DRUG DESIGNATION BY FDA OF PAS-004 FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Reuters·06/02/2026 11:02:00

Please log in to view news